The Department of Health and Human Services yesterday released a fact sheet summarizing federal efforts to address Long COVID — the signs, symptoms and conditions that can continue or develop after initial COVID-19 or SARS-CoV-2 infection. Among other actions, a National Academies of Science, Engineering, and Medicine committee this month will launch a series of public meetings with stakeholders to receive input as it works to refine the federal definition of Long COVID, which will impact how clinicians diagnose and treat it. Also this month, the Agency for Healthcare Research and Quality plans to announce $9 million in funding to help existing Long COVID clinics expand and implement care delivery models.

Related News Articles

Headline
Adults age 65 and older are encouraged to receive an updated dosage of the COVID-19 vaccine, the Centers for Disease Control and Prevention announced April 25…
Headline
The Pfizer and Moderna COVID-19 vaccines can cause myocarditis, but do not appear to cause infertility, Guillain-Barré syndrome, Bell’s palsy, thrombosis with…
Headline
The Food and Drug Administration recently granted emergency use authorization for the first over-the-counter home antigen test to detect both flu and COVID-19…
Headline
Centers for Disease Control and Prevention Director Mandy Cohen, M.D., Feb. 28 endorsed a recommendation by its Advisory Committee on Immunization Practices…
Headline
Paxlovid may no longer be distributed with an emergency use label after March 8, the Food and Drug Administration announced. Providers may dispense unexpired…
Headline
A CDC study  released Dec. 21 found low COVID-19 and flu vaccination coverage for most adults, and low RSV vaccination coverage for adults aged 60 and…